FOOD INCREASES THE BIOAVAILABILITY OF PROPAFENONE

被引:40
作者
AXELSON, JE
CHAN, GLY
KIRSTEN, EB
MASON, WD
LANMAN, RC
KERR, CR
机构
[1] UNIV BRITISH COLUMBIA, DEPT MED, DIV CARDIOL, VANCOUVER V6T 1W5, BC, CANADA
[2] UNIV MISSOURI, SCH MED, KANSAS CITY, MO 64108 USA
[3] UNIV MISSOURI, SCH PHARM, PHARMACOKINET LAB, KANSAS CITY, MO 64108 USA
关键词
D O I
10.1111/j.1365-2125.1987.tb03109.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:735 / 741
页数:7
相关论文
共 30 条
[1]   INFLUENCE OF LONG-TERM INFUSIONS ON LIDOCAINE KINETICS [J].
BAUER, LA ;
BROWN, T ;
GIBALDI, M ;
HUDSON, L ;
NELSON, S ;
RAISYS, V ;
SHEA, JP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :433-437
[2]   EFFECT OF ORAL PROTEIN AND GLUCOSE FEEDING ON SPLANCHNIC BLOOD FLOW AND OXYGEN UTILIZATION IN NORMAL AND CIRRHOTIC SUBJECTS [J].
BRANDT, JL ;
CASTLEMAN, L ;
RUSKIN, HD ;
GREENWALD, J ;
KELLY, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (07) :1017-1025
[3]   PROPAFENONE DISPOSITION KINETICS IN CARDIAC-ARRHYTHMIA [J].
CONNOLLY, S ;
LEBSACK, C ;
WINKLE, RA ;
HARRISON, DC ;
KATES, RE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) :163-168
[4]   CLINICAL-PHARMACOLOGY OF PROPAFENONE [J].
CONNOLLY, SJ ;
KATES, RE ;
LEBSACK, CS ;
HARRISON, DC ;
WINKLE, RA .
CIRCULATION, 1983, 68 (03) :589-596
[5]   THE INFLUENCE OF FOOD ON THE ORAL AND INTRAVENOUS PHARMACOKINETICS OF A HIGH CLEARANCE DRUG - A STUDY WITH LABETALOL [J].
DANESHMEND, TK ;
ROBERTS, CJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (01) :73-78
[6]  
EDWARDS DJ, 1983, 2ND WORLD C CLIN PHA
[7]   EFFECT OF FOOD ON LIDOCAINE KINETICS - MECHANISM OF FOOD-RELATED ALTERATION IN HIGH INTRINSIC CLEARANCE DRUG ELIMINATION [J].
ELVIN, AT ;
COLE, AFD ;
PIEPER, JA ;
ROLBIN, SH ;
LALKA, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :455-460
[8]   DRUG KINETICS AND HEPATIC BLOOD-FLOW [J].
GEORGE, CF .
CLINICAL PHARMACOKINETICS, 1979, 4 (06) :433-448
[9]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF PROPAFENONE IN HUMAN-PLASMA SAMPLES [J].
HARAPAT, SR ;
KATES, RE .
JOURNAL OF CHROMATOGRAPHY, 1982, 230 (02) :448-453
[10]  
HOLLMANN M, 1983, ARZNEIMITTEL-FORSCH, V33-1, P763